BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33398034)

  • 1. Genomic alterations caused by HPV integration in a cohort of Chinese endocervical adenocarcinomas.
    Li W; Lei W; Chao X; Song X; Bi Y; Wu H; Wu M; Li L
    Cancer Gene Ther; 2021 Dec; 28(12):1353-1364. PubMed ID: 33398034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic aberrations in cervical adenocarcinomas in Hong Kong Chinese women.
    Chung TK; Van Hummelen P; Chan PK; Cheung TH; Yim SF; Yu MY; Ducar MD; Thorner AR; MacConaill LE; Doran G; Pedamallu CS; Ojesina AI; Wong RR; Wang VW; Freeman SS; Lau TS; Kwong J; Chan LK; Fromer M; May T; Worley MJ; Esselen KM; Elias KM; Lawrence M; Getz G; Smith DI; Crum CP; Meyerson M; Berkowitz RS; Wong YF
    Int J Cancer; 2015 Aug; 137(4):776-83. PubMed ID: 25626421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Landscape of genomic alterations in cervical carcinomas.
    Ojesina AI; Lichtenstein L; Freeman SS; Pedamallu CS; Imaz-Rosshandler I; Pugh TJ; Cherniack AD; Ambrogio L; Cibulskis K; Bertelsen B; Romero-Cordoba S; Treviño V; Vazquez-Santillan K; Guadarrama AS; Wright AA; Rosenberg MW; Duke F; Kaplan B; Wang R; Nickerson E; Walline HM; Lawrence MS; Stewart C; Carter SL; McKenna A; Rodriguez-Sanchez IP; Espinosa-Castilla M; Woie K; Bjorge L; Wik E; Halle MK; Hoivik EA; Krakstad C; Gabiño NB; Gómez-Macías GS; Valdez-Chapa LD; Garza-Rodríguez ML; Maytorena G; Vazquez J; Rodea C; Cravioto A; Cortes ML; Greulich H; Crum CP; Neuberg DS; Hidalgo-Miranda A; Escareno CR; Akslen LA; Carey TE; Vintermyr OK; Gabriel SB; Barrera-Saldaña HA; Melendez-Zajgla J; Getz G; Salvesen HB; Meyerson M
    Nature; 2014 Feb; 506(7488):371-5. PubMed ID: 24390348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Massively parallel sequencing analysis of 68 gastric-type cervical adenocarcinomas reveals mutations in cell cycle-related genes and potentially targetable mutations.
    Selenica P; Alemar B; Matrai C; Talia KL; Veras E; Hussein Y; Oliva E; Beets-Tan RGH; Mikami Y; McCluggage WG; Kiyokawa T; Weigelt B; Park KJ; Murali R
    Mod Pathol; 2021 Jun; 34(6):1213-1225. PubMed ID: 33318584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic Characterization of HPV-related and Gastric-type Endocervical Adenocarcinoma: Correlation With Subtype and Clinical Behavior.
    Hodgson A; Howitt BE; Park KJ; Lindeman N; Nucci MR; Parra-Herran C
    Int J Gynecol Pathol; 2020 Nov; 39(6):578-586. PubMed ID: 31855952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenetic significance of p53 and c-Ki-ras gene mutations and human papillomavirus DNA integration in adenocarcinoma of the uterine cervix and uterine isthmus.
    Jiko K; Tsuda H; Sato S; Hirohashi S
    Int J Cancer; 1994 Dec; 59(5):601-6. PubMed ID: 7960232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and pathological basis of HPV-negative cervical adenocarcinoma seen in a global study.
    Jenkins D; Molijn A; Kazem S; Pirog EC; Alemany L; de Sanjosé S; Dinjens W; Quint W
    Int J Cancer; 2020 Nov; 147(9):2526-2536. PubMed ID: 32474915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive mapping of the human papillomavirus (HPV) DNA integration sites in cervical carcinomas by HPV capture technology.
    Liu Y; Lu Z; Xu R; Ke Y
    Oncotarget; 2016 Feb; 7(5):5852-64. PubMed ID: 26735580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix.
    Wright AA; Howitt BE; Myers AP; Dahlberg SE; Palescandolo E; Van Hummelen P; MacConaill LE; Shoni M; Wagle N; Jones RT; Quick CM; Laury A; Katz IT; Hahn WC; Matulonis UA; Hirsch MS
    Cancer; 2013 Nov; 119(21):3776-83. PubMed ID: 24037752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-exome sequencing in cervical adenocarcinoma in mainland Chinese patients.
    Zhang X; Guo J; Cai Y; Sheng X
    Transl Cancer Res; 2020 Nov; 9(11):6889-6899. PubMed ID: 35117297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent genomic structural alterations at HPV insertion sites in cervical carcinoma.
    Peter M; Stransky N; Couturier J; Hupé P; Barillot E; de Cremoux P; Cottu P; Radvanyi F; Sastre-Garau X
    J Pathol; 2010 Jul; 221(3):320-30. PubMed ID: 20527025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPV DNA integration site as proof of the origin of ovarian metastasis from endocervical adenocarcinoma: three case reports.
    Arfi A; Hequet D; Bataillon G; Tran-Perennou C; Farkhondeh F; Sastre-Garau X; Fourchotte V; Rouzier R; Laas E; Pouget N; Vincent-Salomon A; Jeannot E
    BMC Cancer; 2019 Apr; 19(1):375. PubMed ID: 31014281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic abnormalities in invasive endocervical adenocarcinoma correlate with pattern of invasion: biologic and clinical implications.
    Hodgson A; Amemiya Y; Seth A; Cesari M; Djordjevic B; Parra-Herran C
    Mod Pathol; 2017 Nov; 30(11):1633-1641. PubMed ID: 28731050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-Wide Profiling of Human Papillomavirus DNA Integration into Human Genome and Its Influence on PD-L1 Expression in Chinese Uygur Cervical Cancer Women.
    Yang-Chun F; Sen-Yu W; Yuan Z; Yan-Chun H
    J Immunol Res; 2020; 2020():6284960. PubMed ID: 32411801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas.
    Seiwert TY; Zuo Z; Keck MK; Khattri A; Pedamallu CS; Stricker T; Brown C; Pugh TJ; Stojanov P; Cho J; Lawrence MS; Getz G; Brägelmann J; DeBoer R; Weichselbaum RR; Langerman A; Portugal L; Blair E; Stenson K; Lingen MW; Cohen EE; Vokes EE; White KP; Hammerman PS
    Clin Cancer Res; 2015 Feb; 21(3):632-41. PubMed ID: 25056374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
    Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T
    Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lobular endocervical glandular hyperplasia is a neoplastic entity with frequent activating GNAS mutations.
    Matsubara A; Sekine S; Ogawa R; Yoshida M; Kasamatsu T; Tsuda H; Kanai Y
    Am J Surg Pathol; 2014 Mar; 38(3):370-6. PubMed ID: 24145653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of oncogenic mutations in cervical carcinoma using method High Resolution Melting (HRM).
    Wayhelova M; Mikulasova A; Smetana J; Vallova V; Blazkova D; Filkova H; Moukova L; Kuglik P
    Neoplasma; 2016; 63(5):779-88. PubMed ID: 27468883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copy number alterations detected by whole-exome and whole-genome sequencing of esophageal adenocarcinoma.
    Wang X; Li X; Cheng Y; Sun X; Sun X; Self S; Kooperberg C; Dai JY
    Hum Genomics; 2015 Sep; 9(1):22. PubMed ID: 26374103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix.
    Ferguson AW; Svoboda-Newman SM; Frank TS
    Mod Pathol; 1998 Jan; 11(1):11-8. PubMed ID: 9556417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.